stonks4u
Sign up free
COCH logo

COCH Envoy Medical, Inc.

NASDAQ Capital Market · Medical - Devices · Healthcare

$0.80
+0.05 (+7.20%)

Envoy Medical, Inc. is a healthcare company dedicated to developing innovative medical technologies that address the full spectrum of hearing loss. Its diverse product portfolio includes conventional hearing aids, Esteem middle ear implants, bone conduction devices, and Acclaim cochlear implants. Established in 1995, the company originally operated as St. Croix Medical, Inc. before officially rebr…

Market Cap: $16.64Mwww.envoymedical.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

78
78
Aug 10Aug 10

Quote

Day Range
$0.74 – $0.81
52-Week Range
$0.36 – $1.89
Volume
$328.1K
Market Cap
$16.64M
50-Day Avg
$0.69
200-Day Avg
$0.70
Prev Close
$0.75
Open
$0.75

Valuation & Ratios

P/E Ratio
-0.54
EPS
$-1.02
P/B Ratio
-1.31
P/S Ratio
63.80
Debt/Equity
-0.08
Current Ratio
0.54
Dividend Yield
+11.8%
Gross Margin
-262.7%

Returns & Efficiency

Return on Equity
+201.9%
Return on Assets
-277.6%
FCF Yield
-119.5%
EV/EBITDA
-0.57

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$241.0K$-23.76M$-1.23
2024$225.0K$-20.80M$-1.49
2023$316.0K$-29.92M$-2.54
2022$237.0K$-15.92M$-1.57
2021$310.0K$-8.68M$-1.05

Social Signal Score

28
5d
—
30d
28
2 mentions
—
60d
28
2 mentions
—
90d
28
2 mentions
—
news: 2

Earnings

Mon, Nov 9(in 3 months)

Consensus estimate $-0.07 per share

3of 7 quarters beat consensus

Typical surprise -8.3% (median, so one quarter with a near-zero estimate can't distort it)

  • Mon, Aug 10$-0.07 vs $-0.08beat
  • Mon, May 11$-0.11 vs $-0.14beat
  • Mon, Mar 23$-0.26 vs $-0.24miss
  • Mon, Nov 10$-0.35 vs $-0.27miss
  • Thu, Jul 31$-0.32 vs $-0.29miss
  • Thu, May 1$-0.29 vs $-0.35beat

Estimates and results for COCH via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

COCHhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (2)

  • Newszacks.com·5d ago·Negative

    Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates Envoy Medical, Inc. (COCH) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.32 per share a year ago.

    View source ↗
  • Newsnewsfilecorp.com·5d ago·Negative

    Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones Submitted First Module of Modular PMA Application to FDA Subsequent to Quarter End, the Company Reported Positive 12-Month Stage 1 Data Showing Continued Improvement in Speech Perception White Bear Lake, Minnesota--(Newsfile Corp. - August 10, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, toda

    View source ↗